期刊文献+

眼部给药系统及影响因素 被引量:1

The ophthalmic drug delivery system and influential factors
下载PDF
导出
摘要 目的对眼部给药系统及影响因素进行综述。方法查阅文献,总结近年来眼部给药系统的最新研究成果、影响眼部给药好坏的因素及提高眼用制剂作用效率的方法。结果眼部给药存在给药屏障,药物可分别经角膜途径和结膜途径发挥局部治疗作用和全身治疗作用。生理因素、药物理化性质及剂型因素均会对药物在眼部传递产生影响。结论通过加入渗透促进剂、改变药物的剂型及减少给药体积可有效提高眼用制剂作用效率。 OBJECTIVE To review the ophthalmic drug delivery system and influential factors. METHODS The research articles of ophthalmic drug delivery system in recent years were referred and summarized. RESULTS The barriers of ocular drug delivery dercrease the drug's concentration in the ocular region, the drug could exert the local or systematic effection through the cornea or conjunctiva pathway. In addition, the ophthalmic drug delivery may be influenced by the physiologic factors, physic-chemical property and the form of the drug. CONCLUSION By adding the penetration enhancer, changing the form of the drug and decreasing the volume of the solvent could dramatically increase the efficiency of the ophthalmic preparation.
作者 李楠 杨明
出处 《海峡药学》 2013年第12期135-136,共2页 Strait Pharmaceutical Journal
关键词 眼部给药 影响因素 给药屏障 角膜途径 结膜途径 Ophthalmic drug delivery system Influential factors The barriers of ocular drug delivery Cornea pathway Conjunctiva pathway
  • 相关文献

参考文献5

二级参考文献71

  • 1李华.透明质酸应用开发近况[J].国外医药(合成药.生化药.制剂分册),1993,14(1):13-15. 被引量:3
  • 2方子年.胶原在眼科制剂和制品中的应用[J].国外医药(合成药.生化药.制剂分册),1993,14(2):103-105. 被引量:5
  • 3梁厚成,惠延年.道诺霉素脂质体防治实验性增殖性玻璃体视网膜病变[J].中华眼底病杂志,1993,9(2):77-80. 被引量:8
  • 4JIANG J, GILL H S, GHATE D, et al. Coated microneedles for drug delivery to the eye [J]. Invest Ophthalmol Vis Sci, 2007, 48(9): 4038-4043.
  • 5JAIN D, CARVALHO E, BANERJEE R. Biodegradable hybrid polymeric membranes for ocular drug delivery [J]. Acta Biomate, 2010, 6(4): 1370-1379.
  • 6IDREES F, VAIDEANU D, FRASER S G, et al. A review of anterior segment dysgeneses [J]. Surv Ophthalmo, 2006, 51(3): 213-231.
  • 7GAUDANA R, JWALA J, SAI H S, et al. Recent perspectives in ocular drug delivery [J]. Pharm Res, 2009, 26(5): 1197-1216.
  • 8DUVVURI S, MAJUMDAR S, MITRA A K. Drug delivery to the retina: challenges and opportunities [J]. Expert Opin Biol Ther, 2003, 3(1): 45-56.
  • 9WADHWA S, PALIWAL R, PALIWAL S R, et al. Nanocarriers in ocular drug delivery: an update review [J]. Curr Pharm Des, 2009, 15(23): 2724-2750.
  • 10CHAN J, MAGHRABY G M, CRAIG J P, et al. Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation [J]. Int J Pharm, 2007, 328(1): 65-71.

共引文献34

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部